Comment on: Myopia, its prevalence, current therapeutic strategy and recent developments: A review.

Indian J Ophthalmol

Department of Ophthalmology, S. S. Medical College, Rewa, Madhya Pradesh, India.

Published: February 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228936PMC
http://dx.doi.org/10.4103/ijo.IJO_2130_22DOI Listing

Publication Analysis

Top Keywords

comment myopia
4
myopia prevalence
4
prevalence current
4
current therapeutic
4
therapeutic strategy
4
strategy developments
4
developments review
4
comment
1
prevalence
1
current
1

Similar Publications

A Competition for the Diagnosis of Myopic Maculopathy by Artificial Intelligence Algorithms.

JAMA Ophthalmol

November 2024

Beijing Institute of Ophthalmology, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Importance: Myopic maculopathy (MM) is a major cause of vision impairment globally. Artificial intelligence (AI) and deep learning (DL) algorithms for detecting MM from fundus images could potentially improve diagnosis and assist screening in a variety of health care settings.

Objectives: To evaluate DL algorithms for MM classification and segmentation and compare their performance with that of ophthalmologists.

View Article and Find Full Text PDF

Genetic methylation in myopia.

Ophthalmic Genet

June 2024

Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

View Article and Find Full Text PDF

Importance: Exotropia and myopia are commonly coexistent. However, evidence is limited regarding atropine interventions for myopia control in children with myopia and intermittent exotropia (IXT).

Objective: To evaluate the efficacy and safety of 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!